Diagnos (ADK.V) said Tuesday it will amend the expiry date of 6.72-million warrants from August 5, 2026 to June 5, 2027.
The warrants were issued as part of a non-brokered private placement of units in February 2025.
All other provisions of the warrants, including the exercise price of C$0.40 per share, remain unchanged.
Diagnos shares were last seen up C$0.00, to C$0.27 on the TSX Venture Exchange.
Price: $0.27, Change: $+0.01, Percent Change: +1.89%